Case number 1:22-cv-00154
Acerta Pharma B.V. et al v. Cipla Limited et al. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 13, 2024 | 158 | SO ORDERED, re 157 Consent Judgment as to Cipla USA, Inc., and Cipla Limited. Attorney Peter L. Giunta; Matthew B. Goeller; Anil H. Patel; Harold M. Storey; Jenna Bruce and Steven L. Caponi terminated. Signed by Judge Gregory B. Williams on 6/12/2024. (lnb) (Entered: 06/13/2024) (3) |
| Jun 11, 2024 | 157 | PROPOSED CONSENT JUDGMENT as to Defendants Cipla Limited and Cipla USA, Inc. by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) (Entered: 06/11/2024) (3) |
| Jun 5, 2024 | 156 | SO ORDERED, re 155 Consent Judgment -- Party Alembic Pharmaceuticals Limited terminated. Attorneys Jovial Wong; Dominick T. Gattuso and Tyree M. Petty-Williams terminated. Signed by Judge Gregory B. Williams on 6/5/2024. (lnb) (Entered: 06/05/2024) (3) |
| May 20, 2024 | 155 | PROPOSED CONSENT JUDGMENT by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Silver, Daniel) (Entered: 05/20/2024) (3) |
| May 8, 2024 | 154 | STIPULATION TO EXTEND TIME the Deadline for the Close of Fact Discovery to June 10, 2024 - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) (Entered: 05/08/2024) (3) |
| May 3, 2024 | 153 | STIPULATION regarding Infringement and Dismissal of Claims - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) Modified on 5/6/2024 (lih). (Entered: 05/03/2024) (5) |
| Apr 16, 2024 | 152 | SO ORDERED, re 150 Consent Judgment as to Natco Pharma Limited and Natco Pharma, Inc. Attorney W. Reid Morris; Christopher J. Sorenson; Jason M. Wiener; James S. Green, Jr and Andrew O. Larsen terminated. Signed by Judge Gregory B. Williams on 4/15/24. (ntl) (Entered: 04/16/2024) (3) |
| Apr 11, 2024 | 151 | NOTICE OF SERVICE of Defendants Third Set of Joint Interrogatories filed by Cipla Limited, Cipla USA, Inc..(Caponi, Steven) (Entered: 04/11/2024) (2) |
| Apr 3, 2024 | 150 | PROPOSED CONSENT JUDGMENT as to Defendants Natco Pharma Limited and Natco Pharma, Inc. by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Silver, Daniel) (Entered: 04/03/2024) (3) |
| Mar 19, 2024 | 149 | SO ORDERED, re 148 Consent Judgment as to Sandoz Inc. -- Party Sandoz Inc. terminated. Signed by Judge Gregory B. Williams on 3/19/24. (ntl) (Entered: 03/19/2024) (4) |
| Mar 18, 2024 | 148 | PROPOSED CONSENT JUDGMENT by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) (Entered: 03/18/2024) (4) |
| Jan 30, 2024 | 146 | STIPULATION TO EXTEND TIME See Stip for Details to - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) (Entered: 01/30/2024) (5) |
| Jan 30, 2024 | 147 | ORDER- GRANTING 146 STIPULATION TO EXTEND TIME. Set SCHEDULING ORDER deadlines: Fact Discovery completed by 5/10/2024, Opening Expert Reports due by 7/19/2024, Rebuttal Expert Reports due by 9/9/2024, Reply Expert Reports due by 10/18/2024, Dispositive Motions due by 12/30/2024, Proposed Pretrial Order due by 2/13/2025. (PLEASE REFER TO ORDER FOR FURTHER DETAILS.) Signed by Judge Sherry R. Fallon on 1/30/2024. (lih) (Entered: 01/30/2024) (5) |
| Jan 26, 2024 | 144 | ORAL ORDER re 143 Stipulation to Extend Discovery Deadlines: The parties' stipulation to extend certain deadlines is DENIED without prejudice. IT IS ORDERED that, on or before January 30, 2024, the parties shall submit a revised stipulation as follows: (1) The deadline for Daubert motions shall be December 30, 2024. The original scheduling order entered by Judge Andrews provided that Daubert motions shall be filed "no later than January 31, 2025 unless otherwise ordered by the Court." (D.I. 30 at ¶ 11(b)) The case was subsequently reassigned to Judge Williams, whose Patent Form Scheduling Order (ANDA) requires Daubert motions to be filed "no later than fourteen (14) days after the close of expert discovery, unless otherwise ordered by the Court." The close of expert discovery is scheduled to occur on December 17, 2024. (2) The deadline for submission of the proposed final pretrial order shall be February 13, 2025. On September 29, 2022, the Court entered an Oral Order instructing the parties to "comply with Judge Williams' pretrial and bench trial procedures as outlined in paragraphs 14, 15, 20 and 21" of Judge Williams form scheduling order for ANDA cases. Paragraph 15 states that "[t]he parties shall file with the Court the joint proposed final pretrial order... not later than seven (7) days before the pretrial conference." Ordered by Judge Sherry R. Fallon on 1/26/2024. (lih) (Entered: 01/26/2024) (0) |
| Jan 26, 2024 | 145 | NOTICE OF SERVICE of Plaintiffs First Supplemental Responses and Objections to Defendants Second Set of Joint Interrogatories (Nos. 1-2) filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Joyce, Alexandra) (Entered: 01/26/2024) (4) |
| Jan 25, 2024 | 143 | STIPULATION TO EXTEND Discovery Deadlines - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) Modified on 1/26/2024 (lih). (Entered: 01/25/2024) (5) |
| Jan 16, 2024 | 142 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' Second Set of Requests for the Production of Documents and Things (Nos. 98-103) and (2) Plaintiffs' Responses and Objections to Defendants' Second Set of Joint Interrogatories (Nos. 12-16) filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Joyce, Alexandra) (Entered: 01/16/2024) (5) |
| Dec 21, 2023 | 141 | NOTICE OF SERVICE of Defendants' Joint Notice of Rule 30(b)(6) Deposition of Plaintiffs filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Haney, Megan) (Entered: 12/21/2023) (2) |
| Dec 19, 2023 | 137 | NOTICE to Take Deposition of '504 '524 and '833 Patent Inventors (See Notice of Deposition) on See Notice of Deposition filed by Alembic Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 12/19/2023) (4) |
| Dec 19, 2023 | 138 | NOTICE to Take Deposition of '083 Patent Inventors (See Notice of Deposition) on See Notice of Deposition filed by Alembic Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 12/19/2023) (4) |
| Dec 19, 2023 | 139 | NOTICE to Take Deposition of '721 and '291 Patent Inventors (See Notice of Deposition) on See Notice of Deposition filed by Alembic Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 12/19/2023) (4) |
| Dec 19, 2023 | 140 | NOTICE to Take Deposition of Dennis Demont, Greg Slatter, Erik Schrader and Peter Carbonaro on See Notice of Deposition filed by Alembic Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 12/19/2023) (4) |
| Dec 13, 2023 | 136 | NOTICE OF SERVICE of Defendants Cipla Limited and Cipla USA Inc.'s Amended Initial Disclosures filed by Cipla Limited, Cipla USA, Inc..(Goeller, Matthew) (Entered: 12/13/2023) (2) |
| Dec 1, 2023 | 135 | NOTICE OF SERVICE of (i) Defendants' Second Set of Requests for the Production of Documents and Things (Nos. 98-102); and, (ii) Defendants' Second Set of Joint Interrogatories (Nos. 12-16) filed by Alembic Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 12/01/2023) (2) |
| Nov 21, 2023 | 134 | NOTICE OF SERVICE of Defendant's Corrected Objections and Responses to Plaintiffs' Notice of Rule 30(b)(6) Deposition of Defendant MSN Pharmaceuticals Inc. filed by MSN Pharmaceuticals Inc..(Haney, Megan) (Entered: 11/21/2023) (2) |
| Nov 17, 2023 | 133 | NOTICE OF SERVICE of Defendant's Objections and Responses to Plaintiffs' Notice of Rule 30(b)(6) Deposition of Defendant MSN Pharmaceuticals Inc. filed by MSN Pharmaceuticals Inc..(Phillips, John) (Entered: 11/17/2023) (2) |
| Nov 16, 2023 | 132 | Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sandoz AG, Corporate Parent Sandoz Group AG for Sandoz Inc. filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 11/16/2023) (2) |
| Oct 27, 2023 | 131 | MOTION for Pro Hac Vice Appearance of Attorney Julie Vernon - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Julie Vernon)Motions referred to Sherry R. Fallon.(Haney, Megan) (Entered: 10/27/2023) (0) |
| Oct 24, 2023 | 130 | NOTICE OF SERVICE of Defendants' Amended Invalidity Contentions filed by Natco Pharma Limited, Natco Pharma, Inc..(Green, James) (Entered: 10/24/2023) (2) |
| Oct 20, 2023 | 129 | REDACTED VERSION of 124 Notice (Other), by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) (Entered: 10/20/2023) (10) |
| Oct 13, 2023 | 119 | NOTICE of Rule 30(b)(1) Depositions of Defendant Cipla's Witnesses (*see Notice for details) by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V. (Joyce, Alexandra) (Entered: 10/13/2023) (2) |
| Oct 13, 2023 | 120 | NOTICE of Rule 30(b)(1) Depositions of Defendant Sandoz's Witnesses (*see Notice for details) by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V. (Joyce, Alexandra) (Entered: 10/13/2023) (2) |
| Oct 13, 2023 | 121 | NOTICE of Rule 30(b)(1) Depositions of Defendant MSN's Witnesses (*see Notice for details) by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V. (Joyce, Alexandra) (Entered: 10/13/2023) (2) |
| Oct 13, 2023 | 122 | NOTICE of Rule 30(b)(1) Depositions of Defendant Natco's Witnesses (*see Notice for details) by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V. (Joyce, Alexandra) (Entered: 10/13/2023) (2) |
| Oct 13, 2023 | 123 | NOTICE of Rule 30(b)(1) Depositions of Defendant Alembic's Witnesses (*see Notice for details) by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V. (Joyce, Alexandra) (Entered: 10/13/2023) (2) |
| Oct 13, 2023 | 124 | [SEALED] NOTICE of Rule 30(b)(6) Deposition of Defendant Alembic Pharmaceuticals Limited by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 10/13/2023) (0) |
| Oct 13, 2023 | 125 | NOTICE of Rule 30(b)(6) Deposition of Defendant Sandoz, Inc. by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V. (Joyce, Alexandra) (Entered: 10/13/2023) (10) |
| Oct 13, 2023 | 126 | NOTICE of Rule 30(b)(6) Deposition of Defendants Natco Pharma Limited and Natco Pharma, Inc. by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V. (Joyce, Alexandra) (Entered: 10/13/2023) (7) |
| Oct 13, 2023 | 127 | NOTICE of Rule 30(b)(6) Deposition of Defendants Cipla Limited and Cipla USA, Inc. by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V. (Joyce, Alexandra) (Entered: 10/13/2023) (9) |
| Oct 13, 2023 | 128 | NOTICE of Rule 30(b)(6) Deposition of Defendant MSN Pharmaceuticals Inc. by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V. (Joyce, Alexandra) (Entered: 10/13/2023) (10) |
| Sep 12, 2023 | 118 | STIPULATION and [Proposed] Order by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) (Entered: 09/12/2023) (4) |
| Aug 30, 2023 | 117 | ORAL ORDER: IT IS HEREBY ORDERED that the Pretrial Conference scheduled for February 21, 2025 is RESCHEDULED for February 20, 2025 at 3:00 PM in Courtroom 6B. ORDERED by Judge Gregory B. Williams on 8/30/23. (ntl) (Entered: 08/30/2023) (0) |
| Jul 31, 2023 | 116 | NOTICE OF SERVICE of Amended Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Cipla Limited, Cipla USA, Inc..(Caponi, Steven) (Entered: 07/31/2023) (2) |
| Jul 19, 2023 | 115 | ANSWER to 107 Answer to Complaint, Counterclaim by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Silver, Daniel) (Entered: 07/19/2023) (8) |
| Jul 18, 2023 | 114 | NOTICE OF SERVICE of Defendants Natco Pharma, Inc. and Natco Pharma Ltd.s Answers to Plaintiffs First Set of Interrogatories Nos. 1-6 filed by Natco Pharma Limited, Natco Pharma, Inc..(Green, James) (Entered: 07/18/2023) (2) |
| Jul 17, 2023 | 112 | NOTICE OF SERVICE of Alembic Pharmaceuticals Limited's Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-6) [CONFIDENTIAL] filed by Alembic Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 07/17/2023) (2) |
| Jul 17, 2023 | 113 | NOTICE OF SERVICE of Sandoz Inc.'s Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-9) [CONFIDENTIAL] filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 07/17/2023) (2) |
| Jul 14, 2023 | 111 | NOTICE OF SERVICE of Defendants MSN Pharmaceuticals, Inc. and MSN Laboratories Private Limited's Responses and Objections to Plaintiffs' Interrogatories (Nos. 1-9) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Haney, Megan) (Entered: 07/14/2023) (2) |
| Jul 10, 2023 | 110 | STIPULATION TO EXTEND TIME the Deadline for the Parties to Substantially Complete Document Production to August 11, 2023 - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) (Entered: 07/10/2023) (4) |
| Jul 5, 2023 | 109 | NOTICE OF SERVICE of Defendants Cipla Ltd. and Cipla USA Inc.'s Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-9) filed by Cipla Limited, Cipla USA, Inc..(Goeller, Matthew) (Entered: 07/05/2023) (2) |
| Jun 28, 2023 | 106 | NOTICE requesting Clerk to remove Sarahi Uribe as co-counsel.. (Joyce, Alexandra) (Entered: 06/28/2023) (2) |
| Jun 28, 2023 | 107 | ANSWER to 1 Complaint, , COUNTERCLAIM against All Plaintiffs by Alembic Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 06/28/2023) (26) |
| Jun 28, 2023 | 108 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Alembic Pharmaceuticals Limited. (Gattuso, Dominick) (Entered: 06/28/2023) (1) |
| Jun 23, 2023 | 105 | MOTION for Pro Hac Vice Appearance of Attorney Chad F. Watson - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Chard F. Watson)Motions referred to Sherry R. Fallon.(Haney, Megan) (Entered: 06/23/2023) (Main Document) (2) |
| Jun 23, 2023 | 105 | MOTION for Pro Hac Vice Appearance of Attorney Chad F. Watson - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Chard F. Watson)Motions referred to Sherry R. Fallon.(Haney, Megan) (Entered: 06/23/2023) (Certification of Chard F. Watson) (1) |
| Jun 22, 2023 | 104 | NOTICE requesting Clerk to remove Jieun Lee as co-counsel. Reason for request: no longer affiliated with the case. (Haney, Megan) (Entered: 06/22/2023) (1) |
| Jun 21, 2023 | 103 | STIPULATION of Dismissal Without Prejudice as to Defendant Alembic Pharmaceuticals, Inc. and Amending Caption by Alembic Pharmaceuticals Limited. (Gattuso, Dominick) (Entered: 06/21/2023) (4) |
| Jun 20, 2023 | 101 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Pvt. Ltd.'s First Set of Requests for Production of Documents and Things (Nos. 1-7) filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Silver, Daniel) (Entered: 06/20/2023) (2) |
| Jun 20, 2023 | 102 | STIPULATION TO EXTEND TIME Alembic to answer, move or otherwise respond to the Complaint to June 28, 2023 - filed by Alembic Pharmaceuticals Limited. (Gattuso, Dominick) (Entered: 06/20/2023) (2) |
| Jun 16, 2023 | 100 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants Cipla Ltd. and Cipla USA Inc.'s First Set of Requests for Admissions (Nos. 1-6) filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Joyce, Alexandra) (Entered: 06/16/2023) (2) |
| Jun 1, 2023 | 99 | NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Defendants filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Silver, Daniel) (Entered: 06/01/2023) (5) |
| May 25, 2023 | 98 | STIPULATION and [Proposed] Order Regarding Service of Complaint Against Alembic and Case Consolidation by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V., AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) (Entered: 05/25/2023) (4) |
| May 22, 2023 | 97 | STIPULATION TO EXTEND TIME to substantially complete document production pursuant to paragraph 4(b) of the Scheduling Order to July 12, 2023 - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Phillips, John) (Entered: 05/22/2023) (3) |
| May 19, 2023 | 96 | NOTICE OF SERVICE of Defendants Cipla Ltd. and Cipla USA Inc.s First Set of Requests for Admission (Nos. 1-6) filed by Cipla Limited, Cipla USA, Inc..(Goeller, Matthew) (Entered: 05/19/2023) (2) |
| May 12, 2023 | 95 | NOTICE OF SERVICE of Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Pvt. Ltd.'s First Set of Requests for Production of Documents and Things (Nos. 1-7) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Haney, Megan) (Entered: 05/12/2023) (2) |
| May 9, 2023 | 94 | NOTICE OF SERVICE of Plaintiffs' Amended Objections and Responses to Defendants Natco Pharma, Inc. and Natco Pharma, Ltd.'s First Set of Requests for Admission to Plaintiffs filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Silver, Daniel) (Entered: 05/09/2023) (2) |
| Apr 28, 2023 | 93 | NOTICE OF SERVICE of Plaintiffs' Amended Rule 26 Initial Disclosures filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Silver, Daniel) (Entered: 04/28/2023) (4) |
| Apr 26, 2023 | 92 | MOTION for Pro Hac Vice Appearance of Attorney W. Reid Morris - filed by Natco Pharma Limited, Natco Pharma, Inc.. Motions referred to Sherry R. Fallon.(Green, James) (lih). Modified on 4/27/2023 (lih). (Entered: 04/26/2023) (2) |
| Mar 30, 2023 | 91 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses Defendants Natco Pharma, Inc. and Natco Pharma, Ltd.'s First Set of Requests for Admission to Plaintiffs, (2) Plaintiffs' Responses and Objections to Defendants Natco Pharma, Inc. and Natco Pharma, Ltd.'s First Set of Interrogatories to Plaintiffs, and (3) Plaintiffs' Objections and Responses to Defendants Natco Pharma, Inc. and Natco Pharma, Ltd.'s First Set of Requests for Production to Plaintiffs filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Silver, Daniel) (Entered: 03/30/2023) (2) |
| Mar 14, 2023 | 90 | ORAL ORDER: IT IS RECOMMENDED that the Court adopt the parties' stipulated claim constructions set forth at D.I. 89 , pages 3-5. The parties' stipulated agreement to vacate the deadlines in the Scheduling Order relating to claim construction is SO ORDERED. (D.I. 30). Signed by Judge Sherry R. Fallon on 3/14/2023. (Polito, Rebecca) (Entered: 03/14/2023) (0) |
| Mar 13, 2023 | 88 | NOTICE requesting Clerk to remove Hayley M. Ostrin as co-counsel. Reason for request: Leaving Firm. (Green, James) (Entered: 03/13/2023) (3) |
| Mar 13, 2023 | 89 | STIPULATION and [Proposed] Order Regarding Claim Construction for U.S. Patent Nos. 9,758,524; 10,239,883; 9,796,721; 10,167,291; 10,272,083 by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) (Entered: 03/13/2023) (7) |
| Mar 9, 2023 | 87 | MOTION for Pro Hac Vice Appearance of Attorney Jason Wiener - filed by Natco Pharma Limited, Natco Pharma, Inc.. Motions referred to Sherry R. Fallon.(Green, James) (Entered: 03/09/2023) (2) |
| Mar 6, 2023 | 86 | STIPULATION TO EXTEND TIME See Stip for Details to - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) (Entered: 03/06/2023) (4) |
| Feb 28, 2023 | 85 | NOTICE OF SERVICE of Defendants Natco Pharma, Inc. and Natco Pharma, Ltd.s First Set of Interrogatories, First Set of Requests for Admission and First Set of Requests for Production to Plaintiffs filed by Natco Pharma Limited, Natco Pharma, Inc..(Green, James) (Entered: 02/28/2023) (2) |
| Feb 23, 2023 | 84 | STIPULATION TO EXTEND TIME the Deadline to Submit a Joint Claim Construction Chart to March 6, 2023 - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) (Entered: 02/23/2023) (3) |
| Feb 13, 2023 | 82 | NOTICE OF SERVICE of Plaintiffs' Proposed Claim Terms for Construction filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Silver, Daniel) (Entered: 02/13/2023) (5) |
| Feb 13, 2023 | 83 | NOTICE OF SERVICE of Defendants' Proposed Terms/Phrases for Claim Construction filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Haney, Megan) (Entered: 02/13/2023) (2) |
| Feb 6, 2023 | 81 | STIPULATION TO EXTEND TIME to Exchange Claim Term(s)/Phrases(s) and Proposed Constructions to February 13, 2023 - filed by Cipla Limited, Cipla USA, Inc.. (Goeller, Matthew) (Entered: 02/06/2023) (3) |
| Jan 18, 2023 | 80 | NOTICE OF SERVICE of Defendant Natco Limiteds Responses to Plaintiffs First Request for the Production of Documents and Things to Natco Limited (Nos. 1-81) filed by Natco Pharma Limited, Natco Pharma, Inc..(Green, James) (Entered: 01/18/2023) (2) |
| Jan 17, 2023 | 76 | NOTICE OF SERVICE of Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Pvt. Ltd.'s Objections and Responses to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-81) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Haney, Megan) (Entered: 01/17/2023) (2) |
| Jan 17, 2023 | 77 | NOTICE OF SERVICE of Alembic's Objections and Responses to Plaintiffs' First Set of Requests for Production (Nos. 1-81) filed by Alembic Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 01/17/2023) (2) |
| Jan 17, 2023 | 78 | NOTICE OF SERVICE of Sandoz's Objections and Responses to Plaintiffs' First Set of Requests for Production (Nos. 1-81) filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 01/17/2023) (2) |
| Jan 17, 2023 | 79 | NOTICE OF SERVICE of Cipla Limited and Cipla USA Inc.'s Objections and Responses to Plaintiff's First Set of Request for Production of Documents filed by Cipla Limited, Cipla USA, Inc..(Goeller, Matthew) (Entered: 01/17/2023) (2) |
| Jan 13, 2023 | 75 | NOTICE requesting Clerk to remove Brian H. Gold as co-counsel. Reason for request: no longer affliated with ArentFox Schiff LLP. (Haney, Megan) (Entered: 01/13/2023) (1) |
| Jan 12, 2023 | 74 | MOTION for Pro Hac Vice Appearance of Attorney Jieun Lee - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Jieun Lee)Motions referred to Sherry R. Fallon.(Haney, Megan) (Entered: 01/12/2023) (Main Document) (2) |
| Jan 12, 2023 | 74 | MOTION for Pro Hac Vice Appearance of Attorney Jieun Lee - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Jieun Lee)Motions referred to Sherry R. Fallon.(Haney, Megan) (Entered: 01/12/2023) (Certification of Jieun Lee) (1) |
| Dec 15, 2022 | 73 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Production to Defendants (Nos. 1-81) filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Joyce, Alexandra) (Entered: 12/15/2022) (5) |
| Dec 2, 2022 | 72 | NOTICE OF SERVICE of Defendants Joint Initial Invalidity Contentions and attached Exhibits and Appendices filed by Natco Pharma Limited, Natco Pharma, Inc..(Green, James) (Entered: 12/02/2022) (2) |
| Nov 30, 2022 | 71 | ORAL ORDER: IT IS ORDERED that, when the Joint Claim Construction Brief is filed on July 31, 2023, the parties shall simultaneously file motions requesting a hearing on claim construction which include the following: (1) a verification that briefing on claim construction is complete; (2) an estimate of how much time is requested for the hearing on August 31, 2023, and (3) a statement regarding whether any live expert witness testimony is anticipated. IT IS FURTHER ORDERED that, no later than August 24, 2023, the parties shall provide an audio-only dial-in number via a joint email to Larisha_Hicks@ded.uscourts.gov. Once the dial-in information is received by the Court, members of the public and/or client representatives may obtain it by contacting Chambers at Larisha_Hicks@ded.uscourts.gov no less than 24 hours before the Markman Hearing on August 31, 2023, at 9:00 a.m. All participants (including any media and members of the public) are reminded that recording or broadcasting proceedings is STRICTLY PROHIBITED. Ordered by Judge Sherry R. Fallon on 11/30/2022. (lih) (Entered: 11/30/2022) (0) |
| Nov 18, 2022 | 70 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' First Set of Joint Requests for the Production of Documents and Things (Nos. 1-97) filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Joyce, Alexandra) (Entered: 11/18/2022) (5) |
| Oct 31, 2022 | 69 | STIPULATION TO EXTEND TIME Defendants to serve Paragraph 4(d) Initial Invalidity Contentions to December 1, 2022 - filed by Natco Pharma Limited, Natco Pharma, Inc.. (Green, James) (Entered: 10/31/2022) (3) |
| Oct 26, 2022 | 68 | NOTICE OF SERVICE of Plaintiffs' Amended Initial Infringement Contentions to Defendant filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Joyce, Alexandra) (Entered: 10/26/2022) (5) |
| Oct 21, 2022 | 67 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' First Set of Joint Interrogatories (Nos. 1-11) filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Joyce, Alexandra) (Entered: 10/21/2022) (5) |
| Sep 29, 2022 | 65 | Stipulated Protective Order by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) Modified on 9/29/2022 (lih). (Entered: 09/29/2022) (29) |
| Sep 29, 2022 | 66 | PROTECTIVE ORDER. Signed by Judge Sherry R. Fallon on 9/29/2022. (lih) (Entered: 09/29/2022) (29) |
| Sep 27, 2022 | 62 | Letter to The Honorable Sherry R. Fallon from John C. Phillips, Jr. regarding Protective Order Dispute. (Attachments: # 1 Exhibit 1, # 2 Proposed Order)(Phillips, John) (Entered: 09/27/2022) (Main Document) (3) |
| Sep 27, 2022 | 63 | Letter to The Honorable Sherry R. Fallon from Daniel M. Silver, Esq. regarding Protective Order Dispute. (Attachments: # 1 Exhibit A, # 2 Text of Proposed Order)(Silver, Daniel) (Entered: 09/27/2022) (Main Document) (4) |
| Sep 27, 2022 | 64 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions to Defendants filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Joyce, Alexandra) (Entered: 09/27/2022) (5) |
| Sep 27, 2022 | 62 | Letter to The Honorable Sherry R. Fallon from John C. Phillips, Jr. regarding Protective Order Dispute. (Attachments: # 1 Exhibit 1, # 2 Proposed Order)(Phillips, John) (Entered: 09/27/2022) (Exhibit 1) (30) |
| Sep 27, 2022 | 62 | Letter to The Honorable Sherry R. Fallon from John C. Phillips, Jr. regarding Protective Order Dispute. (Attachments: # 1 Exhibit 1, # 2 Proposed Order)(Phillips, John) (Entered: 09/27/2022) (Proposed Order) (30) |
| Sep 27, 2022 | 63 | Letter to The Honorable Sherry R. Fallon from Daniel M. Silver, Esq. regarding Protective Order Dispute. (Attachments: # 1 Exhibit A, # 2 Text of Proposed Order)(Silver, Daniel) (Entered: 09/27/2022) (Exhibit A) (30) |
| Sep 27, 2022 | 63 | Letter to The Honorable Sherry R. Fallon from Daniel M. Silver, Esq. regarding Protective Order Dispute. (Attachments: # 1 Exhibit A, # 2 Text of Proposed Order)(Silver, Daniel) (Entered: 09/27/2022) (Text of Proposed Order) (1) |
| Sep 26, 2022 | 61 | STIPULATION to Modify Briefing Schedule re 55 Joint MOTION for Teleconference to Resolve a Protective Order Dispute by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Haney, Megan) Modified on 9/26/2022 (lih). (Entered: 09/26/2022) (4) |
| Sep 23, 2022 | 59 | NOTICE requesting Clerk to remove Karen Beckman as co-counsel. Reason for request: Leaving Firm. (Green, James) (Entered: 09/23/2022) (2) |
| Sep 23, 2022 | 60 | STIPULATION and [Proposed] Order Dismissing Claims Against Cipla Regarding U.S. Patent Nos. 9,758,524 and 10,239,883 Without Prejudice by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) (Entered: 09/23/2022) (3) |
| Sep 22, 2022 | 58 | NOTICE OF SERVICE of (i) Defendants' First Set of Joint Interrogatories (Nos. 1-11); and, (ii) Defendants' First Set of Joint Requests for the Production of Documents and Things (Nos. 1-97) filed by Alembic Pharmaceuticals Limited, Sandoz Inc..(Gattuso, Dominick) (Entered: 09/22/2022) (2) |
| Sep 20, 2022 | 57 | NOTICE OF SERVICE of Defendants Natco Pharma, Inc. & Natco Pharma Ltd.s Supplement of the Initial Disclosures Pursuant to the Delaware Default Standard 3 filed by Natco Pharma Limited, Natco Pharma, Inc..(Green, James) (Entered: 09/20/2022) (2) |
| Sep 13, 2022 | 56 | ORAL ORDER REFERRING CASE TO Magistrate Judge Sherry R. Fallon: IT IS HEREBY ORDERED that the above-captioned case is referred to Magistrate Judge Sherry R. Fallon to hear and resolve all pre-trial matters up to and including expert discovery matters (but not including summary judgment motions, Daubert motions, pre-trial motions in limine or the pre-trial conference), subject to 28 U.S.C. §636(b) and any further Order of the Court. ORDERED by Judge Gregory B. Williams on 9/13/22. (ntl) (Entered: 09/13/2022) (0) |
| Aug 22, 2022 | 55 | Joint MOTION for Teleconference to Resolve a Protective Order Dispute - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. Motions referred to Sherry R. Fallon.(Joyce, Alexandra) Modified on 8/23/2022 (lih). (Entered: 08/22/2022) (5) |
| Aug 11, 2022 | 49 | NOTICE OF SERVICE of Defendant Sandoz Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 08/11/2022) (2) |
| Aug 11, 2022 | 50 | NOTICE OF SERVICE of Alembic's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Alembic Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 08/11/2022) (2) |
| Aug 11, 2022 | 51 | NOTICE OF SERVICE of Defendant MSN Pharmaceuticals Inc. and MSN Laboratories PVT Ltd.'s Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and Paragraphs 4(c)(II) and 4(D) of the Scheduling Order filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Haney, Megan) (Entered: 08/11/2022) (2) |
| Aug 11, 2022 | 52 | NOTICE OF SERVICE of Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard 3 filed by Natco Pharma Limited, Natco Pharma, Inc..(Green, James) (Entered: 08/11/2022) (2) |
| Aug 11, 2022 | 53 | NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Joyce, Alexandra) (Entered: 08/11/2022) (4) |
| Aug 11, 2022 | 54 | NOTICE OF SERVICE of Defendant Cipla Limited and Cipla USA Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Cipla Limited, Cipla USA, Inc..(Caponi, Steven) (Entered: 08/11/2022) (2) |
| Aug 9, 2022 | 48 | ORAL ORDER: The parties have advised that a dispute has arisen regarding an appropriate form of the protective order. This dispute, and any future discovery disputes are now REFERRED to Magistrate Judge Sherry R. Fallon. The parties are directed to refer to Judge Fallon's discovery procedures as outlined on her webpage at the Court's website. Ordered by Judge Richard G. Andrews on 8/9/2022. (nms) (Entered: 08/09/2022) (0) |
| Aug 3, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [47] STIPULATION and Proposed Order to Extend Time to submit a Proposed Protective Order by August 9, 2022. Signed by Judge Richard G. Andrews on 8/3/2022. (nms) |
| Aug 2, 2022 | 47 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME the Deadline to Submit a Proposed Protective Order to August 9, 2022 - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) |
| Jul 26, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [46] STIPULATION and Proposed Order to Extend Time to file Proposed Protective Order to August 2, 2022. Signed by Judge Richard G. Andrews on 7/26/2022. (nms) |
| Jul 25, 2022 | 46 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME Proposed Protective Order to August 2, 2022 - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) |
| Jul 22, 2022 | 45 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Disclosures filed by Natco Pharma Limited, Natco Pharma, Inc..(Green, James) |
| Jul 12, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [40] STIPULATION and Proposed Order to Extend Time to submit a Proposed Protective Order to July 26, 2022. Signed by Judge Richard G. Andrews on 7/12/2022. (nms) |
| Jul 12, 2022 | 41 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Silver, Daniel) |
| Jul 12, 2022 | 42 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic Pharmaceuticals Limited's Rule 26(a) Initial Disclosures filed by Alembic Pharmaceuticals Limited.(Gattuso, Dominick) |
| Jul 12, 2022 | 43 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sandoz Inc.'s Rule 26(a) Initial Disclosures filed by Sandoz Inc..(Gattuso, Dominick) |
| Jul 12, 2022 | 44 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Cipla Limited and Cipla USA Inc.'s Initial Disclosures filed by Cipla Limited, Cipla USA, Inc..(Goeller, Matthew) |
| Jul 11, 2022 | 40 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to July 26, 2022 - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) |
| Jul 8, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Tyree M. Petty-Williams for Alembic Pharmaceuticals Limited and Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Jul 7, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [38] MOTION for Pro Hac Vice Appearance of Attorney Tyree M. Petty-Williams, filed by Sandoz Inc., and [39] MOTION for Pro Hac Vice Appearance of Attorney Tyree M. Petty-Williams, filed by Alembic Pharmaceuticals Limited. Signed by Judge Richard G. Andrews on 7/7/2022. (nms) |
| Jul 7, 2022 | 38 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Tyree M. Petty-Williams - filed by Sandoz Inc.. (Gattuso, Dominick) |
| Jul 7, 2022 | 39 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Tyree M. Petty-Williams - filed by Alembic Pharmaceuticals Limited. (Gattuso, Dominick) |
| Jun 27, 2022 | 37 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to paragraph 4(a) of the Delaware Default Standard for Discovery filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Silver, Daniel) |
| Jun 22, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (27 in 22-cv-155-RGA; 28 in 22-cv-163-RGA; 36 in 22-cv-154-RGA; 32 in 22-cv-164-RGA; 32 in 22-cv-162-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 6/22/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| Jun 22, 2022 | 36 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Certification for Jihad Komis)(Joyce, Alexandra) |
| Jun 22, 2022 | 36 | Certification for Jihad Komis (1) |
| Jun 21, 2022 | 35 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Natco's First Set of Requests for the Production of Documents and Things (Nos. 1-4) filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Joyce, Alexandra) |
| May 16, 2022 | 31 | Answer to Counterclaim (9) Docket Text: ANSWER to [21] Alembic Pharmaceuticals Limited Answer to Complaint, and Counterclaim, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Silver, Daniel) Modified on 5/16/2022 (nms). |
| May 16, 2022 | 32 | Statement (17) Docket Text: Answer to Counterclaims of Cipla Limited and Cipla USA, Inc., by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Silver, Daniel) Modified on 5/16/2022 (nms). |
| May 16, 2022 | 33 | Statement (10) Docket Text: Answer to Counterclaims of MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Silver, Daniel) Modified on 5/16/2022 (nms). |
| May 16, 2022 | 34 | Statement (19) Docket Text: Answer to Counterclaims of Sandoz Inc., by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Silver, Daniel) Modified on 5/16/2022 (nms). |
| May 13, 2022 | 29 | Proposed Order (15) Docket Text: PROPOSED Scheduling Order, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) Modified on 5/13/2022 (nms). |
| May 13, 2022 | 30 | Scheduling Order (13) Docket Text: SCHEDULING ORDER: Joinder of Parties due by 1/9/2023. Amended Pleadings due by 1/9/2023. Fact Discovery completed by 2/12/2024. Joint Claim Construction Brief due by 7/31/2023. A Markman Hearing is set for 8/31/2023, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 2/21/2025, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial on invalidity is set to start 3/3/2025, at 8:30 AM in Courtroom 6A. One day Bench Trials on infringement is set to start 3/10/2025, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| May 11, 2022 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Rule 16(b) Telephone Scheduling Conference held on 5/11/2022. Counsel for Plaintiffs: A. Joyce. Counsel for Defendants: D. Gattuso, M. Haney, M. Goeller. A 3-day Bench Trial on Invalidity is scheduled to begin on 3/3/2025. A Pretrial Conference is set for 2/21/2025, at 9:00 AM. Plaintiff's are directed to resubmit the proposed scheduling order reflecting the rulings the Court made during the hearing. (Court Reporter Heather Triozzi.) Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(lak) |
| May 10, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 24 in 22-cv-155-RGA; D.I. 28 in 22-cv-154-RGA; D.I. 29 in 22-cv-164-RGA; D.I. 29 in 22-cv-162-RGA; D.I. 24 in 22-cv-163-RGA) MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 5/10/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| May 10, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alexander S. Zolan for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 10, 2022 | 28 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) |
| May 9, 2022 | 26 | Proposed Order (16) Docket Text: PROPOSED Scheduling Order, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) Modified on 5/10/2022 (nms). |
| May 9, 2022 | 27 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Alexandra M. Joyce, Esq. regarding Dial-In for Rule 16 Teleconference. (Joyce, Alexandra) |
| Apr 29, 2022 | 25 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Alexandra M. Joyce (Joyce, Alexandra) |
| Apr 28, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 25 in 22-cv-162-RGA; D.I. 25 in 22-cv-164-RGA; D.I. 24 in 22-cv-154-RGA; D.I. 19 in 22-cv-163-RGA) STIPULATION and Proposed Order to Extend Time to Answer, Move, or Respond to the Counterclaims to May 16, 2022. Signed by Judge Richard G. Andrews on 4/28/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| Apr 28, 2022 | 24 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME the Deadline for Plaintiffs to Answer, Move, or Respond to the Counterclaims to May 16, 2022 - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) |
| Apr 13, 2022 | 23 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 5/11/2022, at 3:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 4/13/2022. (nms) |
| Apr 11, 2022 | 21 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against All Plaintiffs, by Alembic Pharmaceuticals Limited.(Gattuso, Dominick) Modified on 4/12/2022 (nms). |
| Apr 11, 2022 | 22 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Alembic Pharmaceuticals Limited. (Gattuso, Dominick) |
| Apr 1, 2022 | 19 | Redacted Document (3) Docket Text: REDACTED VERSION of [15] Stipulation, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Silver, Daniel) |
| Apr 1, 2022 | 20 | Redacted Document (3) Docket Text: REDACTED VERSION of [16] Order, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Silver, Daniel) |
| Mar 31, 2022 | 17 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Claire A. Fundakowski, and Sharon Lin of Winston & Strawn LLP - filed by Alembic Pharmaceuticals Limited. (Gattuso, Dominick) |
| Mar 31, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [17] MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Claire A. Fundakowski, and Sharon Lin of Winston & Strawn LLP, filed by Alembic Pharmaceuticals Limited. Signed by Judge Richard G. Andrews on 3/31/2022. (nms) |
| Mar 4, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jovial Wong for Alembic Pharmaceuticals Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (smg) |
| Mar 3, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The patent report filed at D.I. 14 has been removed as it was entered in error. (nms) |
| Mar 3, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] MOTION for Pro Hac Vice Appearance of Attorney Jovial Wong of Winston & Strawn LLP, filed by Alembic Pharmaceuticals Limited. Signed by Judge Richard G. Andrews on 3/3/2022. (nms) |
| Mar 3, 2022 | 12 | Stipulation of Dismissal (4) Docket Text: STIPULATION of Dismissal Without Prejudice as to Defendant Alembic Pharmaceuticals, Inc., by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Gattuso, Dominick) Modified on 3/3/2022 (nms). |
| Mar 3, 2022 | 13 | Order (4) Docket Text: SO ORDERED Granting [12] Stipulation and Order Dismissing Without Prejudice Defendant Alembic Pharmaceuticals, Inc. and Amending Caption to Reflect Same (*Party Alembic Pharmaceuticals, Inc. terminated). Signed by Judge Richard G. Andrews on 3/3/2022. (nms) |
| Mar 3, 2022 | 14 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jovial Wong of Winston & Strawn LLP - filed by Alembic Pharmaceuticals Limited. (Gattuso, Dominick) |
| Mar 2, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin Hoagland-Hanson, Min Kyung Jeon, Stanley E. Fisher, David I. Berl, and Sarahi Uribe for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(smg) |
| Feb 17, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (12 in 22-cv-164-RGA; 11 in 22-cv-155-RGA; 11 in 22-cv-162-RGA; 11 in 22-cv-163-RGA; 11 in 22-cv-154-RGA) MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 2/17/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| Feb 17, 2022 | 11 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Certifications for David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon)(Joyce, Alexandra) |
| Feb 17, 2022 | 11 | Certifications for David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sar (5) |
| Feb 9, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA (rjb) |
| Feb 9, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION and Order to Extend Time to answer, move or otherwise respond to the Complaint (*Reset Answer Deadlines: Alembic Pharmaceuticals Limited answer due 4/11/2022; Alembic Pharmaceuticals, Inc. answer due 4/11/2022). Signed by Judge Richard G. Andrews on 2/9/2022. (nms) |
| Feb 9, 2022 | 10 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to April 11, 2022 - filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Gattuso, Dominick) |
| Feb 7, 2022 | 8 | Main Document (2) Docket Text: DECLARATION of Service of Alembic Pharmaceuticals Limited, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Exhibits A-B)(Joyce, Alexandra) Modified on 2/10/2022 (nms). |
| Feb 7, 2022 | 8 | Exhibit A-B (7) |
| Feb 7, 2022 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by AstraZeneca AB, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. Alembic Pharmaceuticals, Inc. served on 2/3/2022, answer due 2/24/2022. (Joyce, Alexandra) |
| Feb 2, 2022 | 1 | Main Document (25) Docket Text: COMPLAINT filed against Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3794344.) - filed by AstraZeneca AB, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Exhibit A-E, # (2) Civil Cover Sheet)(mal) |
| Feb 2, 2022 | 1 | Exhibit A-E (520) |
| Feb 2, 2022 | 1 | Civil Cover Sheet (2) |
| Feb 2, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Feb 2, 2022 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 12/28/2021. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: No earlier than 4/30/2025. (mal) |
| Feb 2, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,758,524 ;10,239,883 ;9,796,721 ;10,167,291 ;10,272,083. (mal) |
| Feb 2, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme B.V. filed by Merck Sharp & Dohme B.V.. (mal) |
| Feb 2, 2022 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP and AstraZeneca UK Limited filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (mal) |
| Feb 2, 2022 | 7 | Main Document (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Alembic Pharmaceuticals Limited on 2/2/2022; Alembic Pharmaceuticals, Inc. on 2/2/2022. (Attachments: # (1) Summons Issued)(mal) |
| Feb 2, 2022 | 7 | Summons Issued (2) |
| Feb 2, 2022 | 1 | Complaint* (1) |
